title: Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy.
authors.forename: S
authors.initials: S
authors.lastname: Tuve
authors.forename: J
authors.initials: J
authors.lastname: Gayoso
authors.forename: C
authors.initials: C
authors.lastname: Scheid
authors.forename: J
authors.initials: J
authors.lastname: Radke
authors.forename: A
authors.initials: A
authors.lastname: Kiani
authors.forename: D
authors.initials: D
authors.lastname: Serrano
authors.forename: U
authors.initials: U
authors.lastname: Platzbecker
authors.forename: G
authors.initials: G
authors.lastname: Rodríguez-Macías
authors.forename: M
authors.initials: M
authors.lastname: Wermke
authors.forename: U
authors.initials: U
authors.lastname: Holtick
authors.forename: P
authors.initials: P
authors.lastname: Balsalobre
authors.forename: J M
authors.initials: JM
authors.lastname: Middeke
authors.forename: N
authors.initials: N
authors.lastname: Shayegi
authors.forename: J M
authors.initials: JM
authors.lastname: Chemnitz
authors.forename: A
authors.initials: A
authors.lastname: Krause
authors.forename: N
authors.initials: N
authors.lastname: Gruner
authors.forename: M
authors.initials: M
authors.lastname: Füssel
authors.forename: J
authors.initials: J
authors.lastname: Schetelig
authors.forename: C
authors.initials: C
authors.lastname: Thiede
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
authors.forename: M
authors.initials: M
authors.lastname: Hallek
authors.forename: J L
authors.initials: JL
authors.lastname: Díez-Martín
authors.forename: M
authors.initials: M
authors.lastname: Bornhäuser
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016879:Salvage Therapy; D035781:Siblings; D015996:Survival Rate; D014019:Tissue Donors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide